Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

作者: Bernard Nordlinger , Eric Van Cutsem , Philippe Rougier , Claus-Henning Köhne , Marc Ychou

DOI: 10.1016/J.EJCA.2007.07.017

关键词:

摘要: … The M1 patients would in turn be subdivided into three sub categories: M1a for patients with … For both the M1a and the M1b patients who become resectable, resection offers the …

参考文章(67)
T. Grube, A. Altendorf-Hofmann, R. Stangl, W. Hohenberger, J. Scheele, K. Schmidt, Resektion colorectaler Lebermetastasen Welche Prognosefaktoren bestimmen die Patientenselektion Chirurg. ,vol. 72, pp. 547- 560 ,(2001) , 10.1007/S001040051345
A. de Gramont, Emmanuel Van Cutsem, J. Sastre, A. Cervantes, J. Van Laethem, Yves Humblet, E. Casac, A. Zubel, N. Gascon, Thibaut André, Cetuximab plus oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) for the epidermal growth factor receptor (EGFR)expressing metastatic colorectal cancer (mCRC) in the first-line setting: a phase II study Ejc Supplements. ,vol. 3, pp. 181- 182 ,(2005)
B. Nordlinger, H. Sorbye, L. Collette, B. Glimelius, G. J. Poston, P. M. Schlag, P. Rougier, W. Bechstein, E. Walpole, T. Gruenberger, Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases Journal of Clinical Oncology. ,vol. 25, ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.LBA5
Felix G. Fernandez, John Ritter, J. Wendell Goodwin, David C. Linehan, William G. Hawkins, Steven M. Strasberg, Effect of Steatohepatitis Associated with Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal Metastases Journal of The American College of Surgeons. ,vol. 200, pp. 845- 853 ,(2005) , 10.1016/J.JAMCOLLSURG.2005.01.024
Johannes Scheele, Richard Stang, Annelore Altendorf-Hofmann, Martin Paul, Resection of colorectal liver metastases. World Journal of Surgery. ,vol. 19, pp. 59- 71 ,(1995) , 10.1007/BF00316981
Dominique Elias, Lucas Sideris, Marc Pocard, Jean-Francois Ouellet, Val�rie Boige, Philippe Lasser, Jean-Pierre Pignon, Michel Ducreux, Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Annals of Surgical Oncology. ,vol. 11, pp. 274- 280 ,(2004) , 10.1245/ASO.2004.03.085
D. Jaeck, P. Bachellier, M. Guiguet, K. Boudjema, J. C. Vaillant, P. Balladur, B. Nordlinger, Française de Chirurgie, Long‐term survival following resection of colorectal hepatic metastases British Journal of Surgery. ,vol. 84, pp. 977- 980 ,(2005) , 10.1002/BJS.1800840719
Yuman Fong, David J. Bentrem, CASH (Chemotherapy-Associated Steatohepatitis) costs. Annals of Surgery. ,vol. 243, pp. 8- 9 ,(2006) , 10.1097/01.SLA.0000193599.57858.9B
Bernard Nordlinger, Marguerite Guiguet, Jean-Christophe Vaillant, Pierre Balladur, Karim Boudjema, Philippe Bachellier, Daniel Jaeck, Association Française de Chirurgie, Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients Cancer. ,vol. 77, pp. 1254- 1262 ,(1996) , 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I
R. Stangl, A. Altendorf-Hofmann, R.M. Charnley, J. Scheele, Factors influencing the natural history of colorectal liver metastases. The Lancet. ,vol. 343, pp. 1405- 1410 ,(1994) , 10.1016/S0140-6736(94)92529-1